Immunoproteasomes control activation of innate immune signaling and microglial function.
CNS
UPS
immunoproteasome
microglia
neuroinflammation
proteomics
proteostasis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
06
2022
accepted:
20
09
2022
entrez:
24
10
2022
pubmed:
25
10
2022
medline:
26
10
2022
Statut:
epublish
Résumé
Microglia are the resident immune cells of the central nervous system (CNS) and play a major role in the regulation of brain homeostasis. To maintain their cellular protein homeostasis, microglia express standard proteasomes and immunoproteasomes (IP), a proteasome isoform that preserves protein homeostasis also in non-immune cells under challenging conditions. The impact of IP on microglia function in innate immunity of the CNS is however not well described. Here, we establish that IP impairment leads to proteotoxic stress and triggers the unfolded and integrated stress responses in mouse and human microglia models. Using proteomic analysis, we demonstrate that IP deficiency in microglia results in profound alterations of the ubiquitin-modified proteome among which proteins involved in the regulation of stress and immune responses. In line with this, molecular analysis revealed chronic activation of NF-κB signaling in IP-deficient microglia without further stimulus. In addition, we show that IP impairment alters microglial function based on markers for phagocytosis and motility. At the molecular level IP impairment activates interferon signaling promoted by the activation of the cytosolic stress response protein kinase R. The presented data highlight the importance of IP function for the proteostatic potential as well as for precision proteolysis to control stress and immune signaling in microglia function.
Identifiants
pubmed: 36275769
doi: 10.3389/fimmu.2022.982786
pmc: PMC9584546
doi:
Substances chimiques
NF-kappa B
0
Proteasome Endopeptidase Complex
EC 3.4.25.1
Proteome
0
Protein Kinases
EC 2.7.-
Interferons
9008-11-1
Ubiquitins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
982786Informations de copyright
Copyright © 2022 Çetin, Studencka-Turski, Venz, Schormann, Junker, Hammer, Völker, Ebstein and Krüger.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell Signal. 2021 Sep;85:110048
pubmed: 34015470
J Cell Biol. 2010 Sep 6;190(5):719-29
pubmed: 20819932
Annu Rev Biochem. 2017 Jun 20;86:193-224
pubmed: 28460188
J Neuropathol Exp Neurol. 2020 Feb 1;79(2):123-143
pubmed: 31913484
Front Aging Neurosci. 2022 Jan 05;13:766267
pubmed: 35069173
Cell Biochem Funct. 2022 Mar;40(2):163-174
pubmed: 35043435
J Cancer. 2017 Apr 9;8(7):1129-1136
pubmed: 28607586
J Am Acad Dermatol. 2010 Mar;62(3):489-95
pubmed: 20159315
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14914-9
pubmed: 21852578
Cells. 2021 Sep 27;10(10):
pubmed: 34685535
Genes Dev. 1999 Feb 1;13(3):270-83
pubmed: 9990852
Sci Immunol. 2022 Feb 11;7(68):eabi6763
pubmed: 35148201
Oxid Med Cell Longev. 2020 Mar 27;2020:5497046
pubmed: 32308803
Nat Neurosci. 2007 Nov;10(11):1387-94
pubmed: 17965659
Front Mol Neurosci. 2021 Sep 08;14:733012
pubmed: 34566579
Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102
pubmed: 22251901
Acta Neuropathol Commun. 2020 Oct 20;8(1):170
pubmed: 33081847
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
J Clin Immunol. 2015 Oct;35(7):615-23
pubmed: 26280891
Brain. 2013 May;136(Pt 5):1415-31
pubmed: 23604491
Nat Rev Cancer. 2009 Nov;9(11):798-809
pubmed: 19851315
Cytokine. 2008 May;42(2):145-151
pubmed: 18304834
J Biol Chem. 2006 May 26;281(21):14971-80
pubmed: 16551637
Nat Rev Mol Cell Biol. 2009 Feb;10(2):104-15
pubmed: 19165213
Mol Psychiatry. 2018 Feb;23(2):177-198
pubmed: 29230021
Nat Neurosci. 2018 Oct;21(10):1359-1369
pubmed: 30258234
Acta Neuropathol Commun. 2019 Nov 8;7(1):174
pubmed: 31703599
Hum Mol Genet. 2020 May 8;29(7):1132-1143
pubmed: 32129449
PLoS One. 2019 Jan 25;14(1):e0210888
pubmed: 30682074
Cell. 2010 Aug 20;142(4):613-24
pubmed: 20723761
Annu Rev Biochem. 2001;70:503-33
pubmed: 11395416
Front Mol Neurosci. 2014 Aug 08;7:73
pubmed: 25152710
Curr Opin Virol. 2011 Dec;1(6):455-62
pubmed: 22440909
Front Cell Neurosci. 2020 Aug 06;14:198
pubmed: 32848611
Cells. 2021 Aug 28;10(9):
pubmed: 34571885
Front Aging Neurosci. 2021 Apr 28;13:638208
pubmed: 33994991
Int J Mol Sci. 2018 Feb 01;19(2):
pubmed: 29389898
Acta Neuropathol Commun. 2017 Jun 24;5(1):52
pubmed: 28646899
Front Immunol. 2019 Dec 18;10:2900
pubmed: 31921161
Front Aging Neurosci. 2021 Jun 11;13:682633
pubmed: 34177557
J Clin Invest. 2015 Nov 2;125(11):4196-211
pubmed: 26524591
Am J Hum Genet. 2017 Feb 2;100(2):352-363
pubmed: 28132691
Mol Neurobiol. 2014 Jun;49(3):1422-34
pubmed: 24395130
J Am Soc Nephrol. 2006 Jul;17(7):1807-19
pubmed: 16738015
J Clin Med. 2022 Apr 22;11(9):
pubmed: 35566476
Alzheimers Res Ther. 2015 Aug 19;7(1):56
pubmed: 26286145
Essays Biochem. 2016 Oct 15;60(2):143-151
pubmed: 27744330
J Cell Physiol. 2020 Jan;235(1):442-453
pubmed: 31332784
Sci Rep. 2017 Aug 24;7(1):9365
pubmed: 28839214
Int Immunol. 2021 Mar 1;33(3):127-148
pubmed: 33337480
Front Immunol. 2019 Jun 26;10:1448
pubmed: 31293595
Cells. 2020 Sep 28;9(10):
pubmed: 32998318
Front Microbiol. 2022 Feb 11;12:814635
pubmed: 35222313
J Clin Invest. 2011 Oct;121(10):4150-60
pubmed: 21881205
Int J Mol Sci. 2019 Jul 10;20(14):
pubmed: 31295808
J Neurovirol. 2017 Feb;23(1):47-66
pubmed: 27873219
Front Immunol. 2019 Jan 08;9:3047
pubmed: 30671054
J Cell Mol Med. 2021 Jul;25(14):6786-6799
pubmed: 34132031
Biomolecules. 2021 Jan 05;11(1):
pubmed: 33466553
Biochem Pharmacol. 2010 Mar 1;79(5):706-14
pubmed: 19835847
Am J Hum Genet. 2010 Dec 10;87(6):866-72
pubmed: 21129723
J Clin Invest. 2020 Apr 1;130(4):1912-1930
pubmed: 31917687
Front Immunol. 2017 Aug 09;8:927
pubmed: 28848544
J Clin Immunol. 2017 Feb;37(2):123-132
pubmed: 27943079
Nat Rev Neurosci. 2018 Oct;19(10):622-635
pubmed: 30206328
Nature. 2016 Mar 10;531(7593):237-40
pubmed: 26934225
Anticancer Agents Med Chem. 2017;17(4):483-490
pubmed: 27481554
Sci Rep. 2015 Feb 17;5:8489
pubmed: 25687824
J Neuroinflammation. 2020 Nov 12;17(1):340
pubmed: 33183319
J Mol Med (Berl). 2016 Oct;94(10):1111-1127
pubmed: 27678529
Cell. 2021 Mar 18;184(6):1545-1560
pubmed: 33691137
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Acta Neuropathol Commun. 2019 Feb 14;7(1):20
pubmed: 30764877
J Allergy Clin Immunol. 2019 May;143(5):1939-1943.e8
pubmed: 30664889
Front Immunol. 2018 Mar 02;9:405
pubmed: 29552013
J Neuroinflammation. 2020 Dec 1;17(1):366
pubmed: 33261619
Front Immunol. 2022 Apr 27;13:859703
pubmed: 35572517
Immunology. 2004 Oct;113(2):153-62
pubmed: 15379975
Mol Pain. 2018 Jan-Dec;14:1744806918808150
pubmed: 30280656